Additionally, high NEDD4 expression predicts a poor prognosis in different types of tumors including LUAD (Shen et al., 2020), hepatocellular carcinoma (Hang et al., 2016), gastric cancer (Yang et al., 2012), and colorectal cancer (Eide et al., 2013). This evidence concerns the gene NEDD4 and gastric cancer.